Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study
/in Breast Cancer, Dendritic Cells, International Publications, IOZK VeröffentlichungenRadiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients
/in Cervical Cancer, International Publications[Activation of anti-tumor cytotoxic T lymphocytes by fusion of human dendritic cells and melanoma cells]
/in International Publications, Malignant MelanomaDendritic cell vaccines for the treatment of prostate cancer
/in International Publications, Prostate CancerShort-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo
/in Dendritic Cells, International PublicationsThe induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells
/in International Publications, Malignant MelanomaNewcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma
/in Glioblastoma, International Publications, Newcastle Disease VirusDendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model
/in International Publications, Malignant MelanomaThe anti-tumor effect of human monocyte-derived dendritic cells loaded with HSV-TK/GCV induced dying cells
/in Hepatocellular Carcinoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer